lipoxin a4 has been researched along with 5s,12r,18r-trihydroxy-6z,8e,10e,14z,16e-eicosapentaenoic acid in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 4 (26.67) | 2.80 |
| Authors | Studies |
|---|---|
| Schwab, JM; Serhan, CN | 1 |
| Baumgart, DC; Kang, JX; Weylandt, KH; Wiedenmann, B | 1 |
| Cernadas, M; Haworth, O; Levy, BD; Serhan, CN; Yang, R | 1 |
| Antony, R; Arita, M; Bazan, NG; Hong, S; Marcheselli, VL; Mukherjee, PK; Petasis, NA; Serhan, CN; Sheets, K; Winkler, JW | 1 |
| Agerberth, B; Godson, C; Guiry, PJ; Haeggström, JZ; Wan, M | 1 |
| Braegger, C; Hersberger, M; Klinke, G; Rogler, D; Troxler, H; Weiss, GA | 1 |
| Bao, JJ; Ding, H; Hu, C; Liu, XC; Mei, Q; Xu, JM; Zhao, XW | 1 |
| Abbasinazari, M; Abdi, S; Ahmadpour, F; Dabir, S; Fatehi, S; Hatami, B; Mohammad Alizadeh, AH; Nematollahi, A; Pourhoseingholi, MA | 1 |
| Muralikumar, S; N Das, U; Narayanasamy, A; Vetrivel, U | 1 |
| Aytan, N; Benincasa, C; Carreras, I; Crabtree, L; Dedeoglu, A; Jenkins, BG; Kantarci, A; Palaska, I; Stephens, D | 1 |
| Colas, RA; Dalli, J; De Maeyer, RP; Flint, JD; George, MJ; Gilroy, DW; Motwani, MP; Richard-Loendt, A; Serhan, CN | 1 |
| Dec, K; Drozd, A; Jakubczyk, K; Maciejewska, D; Pilutin, A; Skonieczna-Żydecka, K; Skórka-Majewicz, M; Stachowska, E | 1 |
| Akgül, Ö; Özdemir, AT; Özgül Özdemir, RB; Soysal Gündüz, Ö | 1 |
| Özdemir, AT; Yücel, H | 1 |
| Liu, X; Pan, L; Pang, L; Wang, C; Zhang, Q | 1 |
2 review(s) available for lipoxin a4 and 5s,12r,18r-trihydroxy-6z,8e,10e,14z,16e-eicosapentaenoic acid
| Article | Year |
|---|---|
Lipoxins and new lipid mediators in the resolution of inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Aspirin; Disease Models, Animal; Docosahexaenoic Acids; Eicosapentaenoic Acid; Humans; Inflammation; Lipid Metabolism; Lipoxins; Signal Transduction | 2006 |
Lipoxins and resolvins in inflammatory bowel disease.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Docosahexaenoic Acids; Eicosapentaenoic Acid; Humans; Inflammatory Bowel Diseases; Lipoxins; Treatment Outcome | 2007 |
2 trial(s) available for lipoxin a4 and 5s,12r,18r-trihydroxy-6z,8e,10e,14z,16e-eicosapentaenoic acid
| Article | Year |
|---|---|
Effect of diclofenac on the levels of lipoxin A4 and Resolvin D1 and E1 in the post-ERCP pancreatitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopic Retrograde; Diclofenac; Docosahexaenoic Acids; Eicosapentaenoic Acid; Humans; Lipoxins; Pancreatitis | 2014 |
Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis.
Topics: Administration, Rectal; Adult; Aged; Amylases; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Cholangiopancreatography, Endoscopic Retrograde; Diclofenac; Double-Blind Method; Eicosapentaenoic Acid; Female; Humans; Incidence; Indomethacin; Iran; Lipase; Lipoxins; Male; Middle Aged; Naproxen; Pancreatitis; Risk Factors; Time Factors; Treatment Outcome | 2017 |
11 other study(ies) available for lipoxin a4 and 5s,12r,18r-trihydroxy-6z,8e,10e,14z,16e-eicosapentaenoic acid
| Article | Year |
|---|---|
Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation.
Topics: Animals; Asthma; Disease Models, Animal; Eicosapentaenoic Acid; Inflammation; Inflammation Mediators; Interferon-gamma; Interleukin-23; Lipoxins; Lung; Mice | 2008 |
Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Binding, Competitive; Cell Line; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Eicosapentaenoic Acid; Epoxy Compounds; Humans; Hydrogen Peroxide; Isomerism; Kinetics; Lipoxins; Neuroprotective Agents; Neutrophils; Oxidative Stress; Retinal Pigment Epithelium; Tumor Necrosis Factor-alpha | 2010 |
Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1.
Topics: Antimicrobial Cationic Peptides; Blotting, Western; Calcium; Cathelicidins; Cells, Cultured; Eicosapentaenoic Acid; Electrophoresis, Polyacrylamide Gel; Group IV Phospholipases A2; Humans; Immunoenzyme Techniques; Leukotriene B4; Lipoxins; Neutrophils; Receptors, Formyl Peptide; Receptors, Leukotriene B4; Receptors, Lipoxin | 2011 |
High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation.
Topics: Docosahexaenoic Acids; Eicosanoids; Eicosapentaenoic Acid; Female; Humans; Infant; Infant, Newborn; Inflammation; Lactation; Lipid Metabolism; Lipoxins; Milk, Human; United States | 2013 |
Probing the intermolecular interactions of PPARγ-LBD with polyunsaturated fatty acids and their anti-inflammatory metabolites to infer most potential binding moieties.
Topics: alpha-Linolenic Acid; Anti-Inflammatory Agents; Arachidonic Acid; Binding Sites; Docosahexaenoic Acids; Eicosapentaenoic Acid; gamma-Linolenic Acid; Humans; Kinetics; Linoleic Acid; Linoleic Acids; Lipoxins; Molecular Docking Simulation; Molecular Dynamics Simulation; PPAR gamma; Protein Binding; Protein Interaction Domains and Motifs; Protein Structure, Secondary; Rosiglitazone; Thermodynamics; Thiazolidinediones | 2017 |
Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Hippocampus; Inflammation; Lipoxins; Mice; Mice, Transgenic | 2018 |
Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation.
Topics: Adaptor Proteins, Signal Transducing; Adolescent; Adult; Anti-Inflammatory Agents; Blister; Chemokines; Cytokines; Docosahexaenoic Acids; Eicosanoids; Eicosapentaenoic Acid; Escherichia coli; Humans; Inflammation; Leukocytes; Lipoxins; Male; Middle Aged; Neutrophils; Receptors, Chemokine; Receptors, Formyl Peptide; Receptors, G-Protein-Coupled; Receptors, Lipoxin; Skin; Volunteers; Young Adult | 2018 |
Eicosanoids in Nonalcoholic Fatty Liver Disease (NAFLD) Progression. Do Serum Eicosanoids Profile Correspond with Liver Eicosanoids Content during NAFLD Development and Progression?
Topics: Animals; Biomarkers; Chromatography, Liquid; Dinoprostone; Disease Models, Animal; Disease Progression; Docosahexaenoic Acids; Eicosanoids; Eicosapentaenoic Acid; Hydroxyeicosatetraenoic Acids; Linoleic Acids; Lipoxins; Liver; Male; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley | 2020 |
Low levels of pro-resolving lipid mediators lipoxin-A4, resolvin-D1 and resolvin-E1 in patients with rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Cytokines; Disease Progression; Docosahexaenoic Acids; Eicosapentaenoic Acid; Female; Humans; Inflammation; Inflammation Mediators; Lipid Metabolism; Lipoxins; Male; Middle Aged | 2020 |
Low LXA4, RvD1 and RvE1 levels may be an indicator of the development of hypertension.
Topics: Adult; Arachidonate 15-Lipoxygenase; Blood Pressure; Cholesterol; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertension; Lipoproteins, LDL; Lipoxins; Male; Middle Aged; Oxidation-Reduction; Risk Factors | 2021 |
Combination of resolvin E1 and lipoxin A4 promotes the resolution of pulpitis by inhibiting NF-κB activation through upregulating sirtuin 7 in dental pulp fibroblasts.
Topics: Dental Pulp; Eicosapentaenoic Acid; Fibroblasts; Humans; Lipoxins; NF-kappa B; Pulpitis; Sirtuin 1; Sirtuins | 2022 |